MedPath

Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer

Phase 3
Completed
Conditions
Malnutrition
Gastrointestinal Cancer
Interventions
Other: Dietary counseling
Dietary Supplement: Enteral nutrition
Registration Number
NCT02664974
Lead Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Brief Summary

Phase III, medical, multicentric, controlled, open label, two-parallel groups, randomized, clinical trial.

The aim of this study is to evaluate the efficacy of home enteral nutrition on the nutritional status, the quality of life and tolerance to chemotherapy, in malnourished patients who undergo major gastrointestinal surgery for malignancy (oesophagus, stomach, pancreas, biliary tract). Patients were randomized to receive either home enteral nutrition (HEN, treatment group) or nutritional counselling (control group).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
79
Inclusion Criteria
  • Both gender with age higher than 18 years.
  • Documented cancer of the gastrointestinal tract: oesophagus, stomach, pancreas, biliary tract
  • Candidate for major elective surgery.
  • Preoperative nutritional risk score ≥ 3
  • Written informed consent.
Exclusion Criteria
  • Age < 18 years
  • Karnofsky index < 60
  • Renal insufficiency (Ongoing haemodialysis or plasma creatinine > 3 mg/dL)
  • Respiratory insufficiency
  • Child-Pugh class C
  • Short Bowel Syndrome
  • Pregnancy
  • Emergency operation
  • Foreign residence or residence in Italian region with no regulation designed for home artificial nutrition

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupDietary counselingDietary Counseling
HEN groupEnteral nutritionHome Enteral Nutrition
Primary Outcome Measures
NameTimeMethod
Maintenance of body weight2 months

Evaluated by weight change after discharge

Secondary Outcome Measures
NameTimeMethod
Improvement of tolerance to chemotherapy6 months

Evaluated by the ratio chemotherapy planned / chemotherapy administered

Improvement of quality of life2 months

Evaluated at hospital admission and two months after discharge by the self-administrated Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire

Trial Locations

Locations (2)

European Institute of Oncology

🇮🇹

Milan, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath